학술논문
Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
Document Type
Article
Author
Source
In: Clinical and Applied Thrombosis/Hemostasis . (Clinical and Applied Thrombosis/Hemostasis, January-December 2022, 28)
Subject
Language
English
ISSN
19382723
10760296
10760296